FrancophonIA/ELRC3.0 huggingface dataset:
English: Normal individuals and heterozygous subjects for cystinosis have white cell cystine levels of < 0.2, and usually below 1 nmol hemicystine/mg protein, respectively.
Croatian: Normalni pojedinci imaju razinu cistina u leukocitima < 0,2, a heterozigotni ispitanici na cistinozu imaju razinu manju od 1 nmol hemicistina/mg proteina.
English: Bone disorders reported were genu valgum, leg pain and hyperextensive joints, osteopenia, compression fractures, and scoliosis.
Croatian: Od poremećaja kostiju zabilježeni su genu valgum, bol u nogama i hiperekstenzivni zglobovi, osteopenija, kompresijski prijelomi, i skolioza.
English: Cases of Ehlers-Danlos like syndrome and vascular disorders on elbows have been reported in children treated with high doses of different cysteamine preparations (cysteamine chlorhydrate or cystamine or cysteamine bitartrate) mostly above the maximal dose 1.95 g/m2/day.
Croatian: Zabilježeni su slučajevi sindroma nalik na Ehlers-Danlos i vaskularnih poremećaja na laktovima u djece koja su bila liječena visokim dozama različitih preparata cisteamina (cisteaminkloridom ili cistaminom ili cisteaminditartratom) većinom iznad maksimalne doze od 1,95 g/m2/dan.
English: These skin lesions were associated with vascular proliferation, skin striae and bone lesions.
Croatian: Ove su kožne promjene bile povezivane s vaskularnom proliferacijom, strijama na koži te lezijama kostiju.
English: - A few cases of skin lesions on elbows like little hard lumps have been reported in children treated with high doses of different cysteamine preparations.
Croatian: - Kod djece liječene visokim dozama različitih preparata cisteamina zabilježeno je nekoliko slučajeva kožnih lezija na laktovima nalik na male tvrde kvrge.
English: Very common: Vomiting, nausea, diarrhoea Common: Abdominal pain, breath odour, dyspepsia, gastroenteritis
Croatian: Vrlo često: Povraćanje, mučnina, proljev Često: Bol u trbuhu, zadah, dispepsija, gastroenteritis Manje često: Gastrointestinalni ulkus
English: Uncommon: Joint hyperextension, leg pain, genu valgum, osteopenia, compression fracture, scoliosis.
Croatian: Manje često: Hiperekstenzija zglobova, bol u nogama, genu valgum, osteopenija, kompresijski prijelom, skolioza.
English: Hard Capsule White, opaque hard capsules with CYSTA 50 on the body and MYLAN on the cap.
Croatian: Tvrda kapsula Bijele, neprozirne tvrde kapsule s CYSTA 50 na tijelu i MYLAN na kapici.
English: HOW TO STORE CYSTAGON
Croatian: KAKO ČUVATI CYSTAGON
English: Hard Capsule White, opaque hard capsules with CYSTAGON 150 on the body and MYLAN on the cap.
Croatian: Tvrda kapsula Bijele, neprozirne tvrde kapsule s CYSTAGON 150 na tijelu i MYLAN na kapici.
English: CYSTAGON 50 mg Hard Capsules CYSTAGON 150 mg Hard Capsules Cysteamine bitartrate (mercaptamine bitartrate)
Croatian: CYSTAGON 50 mg tvrde kapsule CYSTAGON 150 mg tvrde kapsule cisteaminditartarat (merkaptaminditartarat)
English: Each hard capsule contains 50 mg of cysteamine (as mercaptamine bitartrate) .
Croatian: Svaka tvrda kapsula sadrži 50 mg cisteamina (u obliku merkaptaminditartarata).
English: EU/1/97/039/001 - 100 hard capsules EU/1/97/039/002 - 500 hard capsules
Croatian: EU/1/97/039/001 - 100 tvrdih kapsula EU/1/97/039/002 - 500 tvrdih kapsula
English: EU/1/97/039/003 - 100 hard capsules EU/1/97/039/004 - 500 hard capsules
Croatian: EU/1/97/039/003 - 100 tvrdih kapsula EU/1/97/039/004 - 500 tvrdih kapsula
English: Each hard capsule contains 150 mg of cysteamine (as mercaptamine bitartrate) .
Croatian: Svaka tvrda kapsula sadrži 150 mg cisteamina (u obliku merkaptaminditartarata).
English: Very common: Lethargy, pyrexia Common: Asthenia
Croatian: Vrlo često: Letargija, vrućica Često: Astenija
English: EU/1/97/039/001 (100 hard capsules per bottle), EU/1/97/039/002 (500 hard capsules per bottle).
Croatian: EU/1/97/039/001 (100 tvrdih kapsula u bočici), EU/1/97/039/002 (500 tvrdih kapsula u bočici).
English: EU/1/97/039/003 (100 hard capsules per bottle), EU/1/97/039/004 (500 hard capsules per bottle).
Croatian: EU/1/97/039/003 (100 tvrdih kapsula u bočici), EU/1/97/039/004 (500 tvrdih kapsula u bočici).
English: CYSTAGON 150 mg hard capsules Cysteamine
Croatian: CYSTAGON 150 mg tvrde kapsule cisteamin
English: CYSTAGON 150 mg hard capsules
Croatian: CYSTAGON 150 mg tvrde kapsule
English: BOTTLE LABEL CYSTAGON 150 mg x 100 hard capsules BOTTLE LABEL CYSTAGON 150 mg x 500 hard capsules
Croatian: NALJEPNICA NA BOČICI CYSTAGON 150 mg x 100 tvrdih kapsula NALJEPNICA NA BOČICI CYSTAGON 150 mg x 500 tvrdih kapsula
English: BOTTLE LABEL CYSTAGON 50 mg x 100 hard capsules BOTTLE LABEL CYSTAGON 50 mg x 500 hard capsules
Croatian: NALJEPNICA NA BOČICI CYSTAGON 50 mg x 100 tvrdih kapsula NALJEPNICA NA BOČICI CYSTAGON 50 mg x 500 tvrdih kapsula
English: CYSTAGON 50 mg hard capsules
Croatian: CYSTAGON 50 mg tvrde kapsule
English: You should contact your or your child's doctor or the hospital emergency department immediately if more medicine has been taken than has been prescribed, drowsiness develops .
Croatian: Ako primjenite više lijeka CYSTAGON nego što ste trebali Trebate odmah obavijestiti svog liječnika ili liječnika Vašeg djeteta ili odjel za hitnu službu u bolnici.
English: OUTER CARTON CYSTAGON 150 mg x 100 hard capsules OUTER CARTON CYSTAGON 150 mg x 500 hard capsules
Croatian: VANJSKA KARTONSKA KUTIJA CYSTAGON 150 mg x 100 tvrdih kapsula VANJSKA KARTONSKA KUTIJA CYSTAGON 150 mg x 500 tvrdih kapsula
English: OUTER CARTON CYSTAGON 50 mg x 100 hard capsules OUTER CARTON CYSTAGON 50 mg x 500 hard capsules
Croatian: VANJSKA KARTONSKA KUTIJA CYSTAGON 50 mg x 100 tvrdih kapsula VANJSKA KARTONSKA KUTIJA CYSTAGON 50 mg x 500 tvrdih kapsula
English: CYSTAGON 50 mg hard capsules Cysteamine
Croatian: CYSTAGON 50 mg tvrde kapsule cisteamin
English: Hypersensitivity to the active substance or to any of the excipients The use of CYSTAGON is contra-indicated during breast-feeding.
Croatian: Korištenje CYSTAGONA kontraindicirana je tijekom dojenja.
English: Recordati Rare Diseases Immeuble “Le Wilson” 70, Avenue du Général de Gaulle F-92800 Puteaux France
Croatian: Recordati Rare Diseases Immeuble “Le Wilson” 70, Avenue du Général de Gaulle F-92800 Puteaux Francuska
English: - CYSTAGON has not been shown to prevent cystine crystals accumulating in the eye. Where cysteamine ophthalmic solution has been used for that purpose, its usage should continue.
Croatian: - Nije se pokazalo da CYSTAGON sprečava nakupljanje kristala cistina u oku.
English: <Content (concentration)>
Croatian: Sastav (koncentracija)
English: Immediate Packaging
Croatian: Pakovanje
English: Date of first authorisation: 06/11/2015.
Croatian: Datum prvog odobrenja: 06/11/2015.
English: This is particularly important when injecting small volumes.
Croatian: To je naročito važno kad se ubrizgavaju male količine.
English: Avoid contact with the eyes and skin.
Croatian: Izbjegavajte kontakt s očima ili kožom.
English: EXP {month/year} Once broached, use by __/__/__
Croatian: EXP {mjesec/godina} Jednom odčepljen, upotrijebiti do __/__/__
English: Do not administer Dose 2 on Day 10.
Croatian: Nemojte davati 2. dozu na 10. dan.
English: Pack size of 1.
Croatian: Veličina pakovanja od 1.
English: Therefore, use only according to the benefit/risk assessment by the responsible veterinarian.
Croatian: Prema tome, primijeniti samo nakon procjene odnosa koristi/rizika od strane odgovornog veterinara.
English: Once the optimal dose and dosing interval have been determined, maintain the same regimen.
Croatian: Jednom kada su određeni optimalna doza i interval doziranja, održavajte isti režim.
English: For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
Croatian: Za informacije o ovom veterinarsko-medicinskom proizvodu molimo kontaktirajte lokalnog predstavnika nositelja odobrenja za stavljanje u promet.
English: Before starting treatment with the veterinary medicinal product, it is important that Addison's disease has been definitively diagnosed.
Croatian: Prije početka liječenja s veterinarsko-medicinskim proizvodom, važno je prethodno definitivno dijagnosticirati Addisonovu bolest.
English: Zycortal is an opaque white suspension.
Croatian: Zycortal je neprozirna bijela suspenzija.
English: Zycortal replaces the mineralocorticoid hormones only.
Croatian: Zycortal zamjenjuje samo mineralokortikoidne hormone.
English: Prior to a stressful situation, consider temporarily increasing the dose of glucocorticoid.
Croatian: Prije stresne situacije, razmislite o privremenom povećanju doze glukokortikoida.
English: Use an appropriately graduated syringe to accurately administer the required dose volume.
Croatian: Koristite odgovarajuće graduiranu štrcaljku kako biste mogli precizno primijeniti potrebnu dozu.
English: This product may cause adverse developmental effects on unborn children and neonates.
Croatian: Ovaj proizvod može nepoželjno djelovati na razvoj nerođene djece i novorođenčadi.
English: In case of accidental spillage onto the skin or eyes, wash the affected area with water.
Croatian: U slučaju nenamjernog prolijevanja na kožu ili u oči, isperite to područje s vodom.
English: Eurovet Animal Health B.V. Handelsweg 25
Croatian: Eurovet Animal Health B.V.
English: Subsequent doses and long term management:
Croatian: Naredne doze i dugotrajni režim:
English: ≥ 24 to < 27
Croatian: ≥ 24 do < 27
English: 32 to < 34
Croatian: 32 do < 34
English: This product may cause adverse effects on male reproductive organs and, as a result, fertility.
Croatian: Proizvod može uzrokovati nepoželjno djelovanje na muške reprodukcijske organe te stoga i na plodnost.
English: Second dose of Zycortal:
Croatian: Druga doza Zycortala:
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton and the vial after EXP.
Croatian: Ne koristite ovaj veterinarsko-medicinski proizvod poslije isteka roka valjanosti naznačenog na kutiji i bočici nakon EXP.
English: Opaque white suspension.
Croatian: Neprozirna bijela suspenzija.
English: Pancreas disorders have been reported very rarely following use of Zycortal.
Croatian: Znakovi poremećaja funkcije gušterače su prijavljeni vrlo rijetko nakon primjene Zycortala.
English: The concurrent administration of glucocorticoids may contribute to these signs.
Croatian: Istovremena primjena glukokortikoida može pridonijeti tim znakovima.
English: This product may cause pain and swelling at the injection site if accidentally self-administered.
Croatian: Proizvod može dovesti do boli i oticanja na mjestu uboda ako se nehotično samoinjicira.
English: Marketing authorisation holder: Dechra Regulatory B.V.
Croatian: Nositelj odobrenja za stavljanje u promet: Dechra Regulatory B.V.
English: In case of signs of overdose, the dog should be treated symptomatically, and subsequent doses reduced.
Croatian: U slučaju znakova predoziranja, psa treba liječiti simptomatski, a naredne doze treba smanjiti.
English: Zycortal is intended for long term administration at intervals and doses dependent upon individual response.
Croatian: Zycortal je namijenjen za dugotrajnu primjenu u intervalima i dozama koji ovise o individualnoj reakciji na liječenje.
English: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Croatian: Svi neupotrebljeni veterinarsko-medicinski proizvodi ili otpadni materijali dobiveni primjenom tih veterinarsko-medicinskih proizvoda trebaju se odlagati u skladu s lokalnim propisima
English: 5531 AE Bladel The Netherlands
Croatian: 5531 AE Bladel Nizozemska
English: Pharmacotherapeutic group: corticosteroids for systemic use, mineralocorticoids ATCvet code: QH02AA03
Croatian: Farmakoterapijska grupa: kortikosteroidi za sustavnu primjenu, mineralokortikoidi ATCvet kod: QH02AA03
English: If the dog's clinical signs have worsened or not resolved, adjust the dose of glucocorticoid and/or investigate other causes of the clinical signs.
Croatian: Ako se psu kliničko stanje pogoršalo ili se nije popravilo, prilagodite dozu glukokortikoida i/ili istražite druge uzroke kliničkih simptoma.
English: Do not store above 30 C.
Croatian: Nemojte čuvati pri temperaturi iznad 30 C.
English: 4.7 Use during pregnancy, lactation or lay
Croatian: 4.7 Primjena tijekom graviditeta laktacije ili nesenja
English: For use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison's disease).
Croatian: Koristi se kao nadomjesna terapija za nedostatak mineralokortikoida kod pasa s primarnim hipoadrenokorticizmom (Addisonova bolest).
English: • If the dog is both clinically normal and has a normal Na
Croatian: • Ako je kliničko stanje psa normalno i ima normalni omjer Na
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - Rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Croatian: Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu(e) ) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja) - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
English: The safety of the veterinary medicinal product has not been established during breeding, pregnancy or lactation.
Croatian: Neškodljivost veterinarsko-medicinskog proizvoda nije utvrđena za vrijeme graviditeta ili laktacije.
English: The osmotic gradient promotes water absorption from the renal tubules resulting in increased extracellular fluid volume, leading to blood volume expansion, improved venous return to the heart, and increased cardiac output.
Croatian: Osmotski gradijent promovira upijanje vode iz bubrežnih tubula što dovodi do povećanja izvan staničnog volumena tekućine, što dovodi do povećanja volumena krvi, poboljšanja venskog povratka u srce i jačeg srčanog otkucaja.
English: Prior to use, gently shake the vial to resuspend the product.
Croatian: Prije uporabe, lagano protresite bočicu da se proizvod promiješa.
English: Evaluate the electrolytes every 5-9 days until the Na⁺/K⁺ ratio is < 32, and then administer 2.2 mg/kg of Zycortal.
Croatian: Procjenjujte elektrolite svakih 5 do 9 dana sve dok omjer Na⁺/K⁺ ne bude < 32, a nakon toga primijenite 2,2 mg/kg Zycortala.
English: In a clinical trial, very common adverse reactions were polydipsia and polyuria.
Croatian: U kliničkim ispitivanjima vrlo česte nuspojave su bile polidipsija i poliurija.
English: 27 to < 32
Croatian: 27 do < 32
English: Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Croatian: Ne primjenjivati u slučaju preosjetljivosti na djelatnu tvar ili na neku od pomoćnih tvari.
English: In a clinical trial, very common adverse reactions were polydipsia (excessive drinking) and polyuria (excessive urination).
Croatian: U kliničkim ispitivanjima, vrlo česte nuspojave bile su polidipsija (pretjerano konzumiranje vode) i poliurija (pretjerano mokrenje).
English: Type I glass vial (containing 4 ml) with a coated chlorobutyl rubber stopper and aluminium seal with a plastic flip-off cap.
Croatian: I (sadržava 4 ml) s gumenim čepom obloženim klorobutilom te zatvaračem od aluminija i plastičnim čepom flip-off.
English: Desoxycortone is a corticosteroid with primarily mineralocorticoid activity, similar to aldosterone.
Croatian: Dezoksikorton je kortikosteroid s primarno mineralokortikoidnim djelovanjem, sličan aldosteronu.
English: • Clinical signs of depression, lethargy, vomiting, diarrhoea or weakness: Increase the glucocorticoid dose.
Croatian: • Klinički znakovi depresije, letargije, povraćanja, proljeva ili malaksalosti: povećajte dozu glukokortikoida.
English: Tailor the dose of Zycortal and the concurrently administered glucocorticoid replacement therapy to the individual dog based on clinical response and normalization of Na⁺ and K⁺ serum concentrations.
Croatian: Prilagodite dozu Zycortala i istovremeno davane zamjenske terapije glukokortikoidima za svakog psa pojedinačno na temelju kliničkog odgovora i normalizacije serumske koncentracije Na⁺ i K⁺.
English: • Clinical signs of polyuria/polydipsia: Decrease the glucocorticoid dose first.
Croatian: • Klinički znakovi poliurije/polidipsije: prvo smanjite dozu glukokortikoida.
English: Shelf life after first opening the container: 120 days.
Croatian: Rok valjanosti poslije prvog otvaranja spremnika: 120 dana.
English: Sodium chloride Chlorocresol
Croatian: Natrijev klorid
English: Manufacturer responsible for batch release: Dales Pharmaceuticals Limited Snaygill Industrial Estate Keighley Road
Croatian: Proizvođač odgovoran za puštanje serije u promet: Dales Pharmaceuticals Limited Snaygill Industrial Estate Keighley Road
English: Any dog presenting with severe hypovolaemia, dehydration, prerenal azotaemia and inadequate tissue perfusion (also known as “Addisonian crisis”) must be rehydrated with intravenous fluid (saline) therapy before starting treatment with the veterinary medicinal product.
Croatian: Ako pas pokazuje znakove teške hipovolemije, dehidracije, prerenalne azotemije i nedovoljne prokrvljenosti tkiva (poznato i kao „Addisonska kriza“), treba ga rehidrirati s intravenoznim tekućinama (fiziološka otopina) prije početka liječenja s veterinarsko-medicinskim proizvodom.
English: Pregnant and breast-feeding women should avoid administration of this product.
Croatian: Trudnice ili dojilje ne bi smjele primjenjivati ovaj proizvod.
English: • Hyperkalaemia, hyponatremia or Na⁺/K⁺ ratio < 27: Decrease the Zycortal dosing interval by 2-3 days or increase the dose.
Croatian: • Hiperkalemia, hiponatremija ili omjer Na⁺/K⁺ < 27: smanjite interval doziranja Zycortala za 2 do 3 dana ili povećajte dozu.
English: Re-evaluate the dog and measure the serum sodium/potassium ratio (Na⁺/K⁺ ratio) approximately 10 days after the first dose (which is the time to maximum concentration (Tmax) of desoxycortone).
Croatian: Ponovno procijenite stanje psa i izmjerite omjer natrija i kalija (Na⁺/K⁺ omjer) u serumu otprilike 10 dana nakon prve doze (to je vrijeme maksimalne koncentracije (Tmax) dezoksikortona).
English: If the dog develops abnormal clinical signs or Na⁺ or K⁺ serum concentrations, use the following guidelines for subsequent doses:
Croatian: Ako se kod psa pojave abnormalni klinički simptomi ili serumske koncentracije natrija i kalija, slijedite sljedeće smjernice za naredne doze:
English: Dechra Regulatory B.V. Handelsweg 25
Croatian: Dechra Regulatory B.V.
English: Dogs with combined glucocorticoid and mineralocorticoid deficiency should also receive a glucocorticoid such as prednisolone in accordance with standard texts.
Croatian: Psi s kombinacijom nedostatka glukokortikoida i mineralokortokida također bi trebali primati glukokortikoid kao što je prednizolon, u skladu sa standardnim uputama.
English: Polyuria, polydipsia may be observed.
Croatian: Mogu se pojaviti poliurija, polidipsija.
English: In the kidney, desoxycortone causes sodium and chloride ion retention, and hydrogen and potassium ion excretion, creating an osmotic gradient.
Croatian: U bubregu, dezoksikorton uzrokuje zadržavanje natrijevih i kloridih iona, te izlučivanje vodikovih i kalijevih iona, kreirajući tako osmotski gradijent.
English: Use with caution in dogs with congestive heart disease, severe renal disease, primary hepatic failure or oedema.
Croatian: Koristite s oprezom kod pasa s urođenom bolesti srca, teškom bolesti bubrega, primarnim zatajenjem jetre ili edemom.
English: Methylcellulose Sodium carboxymethylcellulose Polysorbate 60
Croatian: Natrijeva carboksimetilceluloza Polisorbat 60
English: After subcutaneous administration of desoxycortone pivalate at a dosage of 11 mg/kg body weight (five times the recommended dosage), the plasma half-life (mean ± standard deviation) is approximately 17 ± 7 days, with a maximum concentration (Cmax) of 13.2 ± 5 ng/ml, and time to maximum concentration (Tmax) of 10 ± 3.5 days.
Croatian: Nakon potkožne primjene dezoksikorton pivalata u dozama od 11 mg/kg tjelesne težine (pet puta veća doza od preporučene), poluživot u plazmi (srednje± standardno odstupanje) je otprilike 17 ± 7 dana, s maksimalnim koncentracijama (Cmax) 13,2 ± 5 ng/ml, i vremenom do maksimalne koncentracije (Tmax) 10 ± 3,5 dana.
English: Initial dose of Zycortal: The initial dose is 2.2 mg/kg body weight, administered by subcutaneous injection.
Croatian: Početna doza Zycortala: Početna doza je 2,2 mg/kg tjelesne težine, potkožnom injekcijom.
English: Shelf life after first opening the immediate packaging: 120 days.
Croatian: Rok valjanosti poslije prvog otvaranja unutarnjeg pakovanja: 120 dana.
English: If the polyuria/polydipsia persists and the Na⁺/K⁺ ratio is >32, then decrease the dose of Zycortal without changing the dosing interval.
Croatian: Ako poliurija/polidipsija ustraju, a omjer Na⁺/K⁺ je >32, onda smanjite dozu Zycortala bez da mijenjate i interval između doza.
English: Hypertension has been observed in dogs receiving 20 mg/kg of desoxycortone pivalate.
Croatian: Visoki krvni tlak primijećen je kod pasa koji su primali 20 mg/kg dezoksikorton pivalata.
English: As expected from the pharmacodynamic effects, escalating doses of desoxycortone are associated with a dose-related trend for increased serum sodium, and decreased blood urea nitrogen, serum potassium and urine specific gravity.
Croatian: Kao što se može očekivati od farmakodinamičkih svojstava, povećanje doze dezoksikorton pivalata dovodi do povišenog serumskog natrija i smanjene dušične ureje u krvi, serumskog kalija i specifične težine urina.
English: Second dose of Zycortal: At approximately 25 days after the first dose, re-evaluate the dog and measure the Na⁺/K⁺ ratio.
Croatian: Druga doza Zycortala: Otprilike 25 dana nakon prve doze, procijenite stanje psa i izmjerite odnos Na⁺/K⁺.
English: Table 1: Day 25: Administering the Second Dose of Zycortal If the Day 10 Na⁺/K⁺ ratio is:
Croatian: Tabela 1: dan 25.: primjena druge doze Zycortala: Ako je 10. dana odnos između Na⁺/K⁺:
English: If the dog is clinically normal and the Day 25 Na⁺/K⁺ ratio is > 32, it is possible to prolong the dosing interval instead of adjusting the dose as described in Table 1.
Croatian: Ako je kliničko stanje psa normalno i omjer Na⁺/K⁺ na 25. dan je > 32, moguće je produljiti interval između doza umjesto prilagoditi dozu kao što je opisano u Tabeli 1.
English: Common reactions were inappropriate urination, lethargy, alopecia, panting, vomiting, decreased appetite, anorexia, decreased activity, depression, diarrhoea, polyphagia, shaking, tiredness and urinary tract infections.
Croatian: Česte reakcije bile su neprilično mokrenje, letargija, alopecija, dahtanje, povraćanje, smanjeni apetit, anoreksija, smanjenje aktivnosti, depresija, proljev, polifagija, drhtanje, umor i upale mokraćnih puteva.
English: Disposal: Read package leaflet.
Croatian: Odlaganje: pročitati uputu o VMP.
English: When given to dogs at three to five times the recommended dose, injection site reactions characterised by erythema and oedema occurred.
Croatian: Kada je proizvod davan psima u dozama koje su tri do pet puta veće od preporučene doze, reakcije na mjestu uboda bile su okarakterizirane crvenilom i otokom.
English: At approximately 25 days after the first dose, re-evaluate the dog and measure the Na⁺/K⁺ ratio.
Croatian: Otprilike 25 dana nakon prve doze, procijenite stanje psa i izmjerite omjer Na⁺/K⁺.